Zura Bio Limited (ZURA)
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.
$5.40-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+259.7%
The outlook
Zura Bio Limited currently reads as bullish based on strong buy — 1.1 avg of 6 analysts, above its 50- & 200-day averages, 66% of the way from its 52-week low to high, avg target +190% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 6 analysts
Price trendAbove its 50- & 200-day averages
52-week range66% of the way from its 52-week low to high
Price targetAvg target +190% vs current price
Analyst price target
~12-month · 6 analysts$15.67average target+190.4% vs now
Now $5.40
Low $11.00High $26.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$511.9M
52-wk high
$7.44
52-wk low
$1.35
50-day avg
$4.63
200-day avg
$4.98
Trailing P/E
—